Interventional Radiology Market to Reach USD 42.82 Billion by 2033 at 8.5% CAGR | North America Holds 39% Share | Key Players: Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare

The Interventional Radiology Market was valued at USD 22.13 billion in 2024 and is projected to reach USD 42.82 billion by 2033, expanding at a CAGR of 8.5% during the forecast period from 2025 to 2033. This strong growth is driven by increasing clinical adoption of minimally invasive procedures, rising prevalence of chronic diseases such as cardiovascular and oncologic conditions, and growing demand for image-guided diagnostic and therapeutic interventions that reduce hospital stays and improve patient outcomes. Interventional radiology techniques are increasingly preferred over traditional surgical approaches due to lower risk, faster recovery times, and greater procedural precision.

Technological advancements in imaging modalities, navigation systems, and therapeutic devices are accelerating innovation across the interventional radiology ecosystem. Enhanced real-time imaging, robotics integration, and AI-assisted procedural planning are improving accuracy, workflow efficiency, and clinician confidence. Recent industry momentum includes expanded use of interventional procedures for stroke management, peripheral artery disease, uterine fibroid embolization, tumor ablation, and targeted drug delivery. Strategic collaborations between device manufacturers and healthcare providers are also facilitating broader access to advanced interventional solutions in both developed and emerging markets. These developments are positioning interventional radiology as a cornerstone of modern minimally invasive care, supporting improved clinical outcomes and reduced healthcare costs globally.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/interventional-radiology-market?sai-v

Interventional Radiology Market refers to the industry focused on minimally invasive, image-guided medical procedures and the devices, technologies, and services used to diagnose and treat a wide range of conditions through targeted therapeutic interventions.

Key Developments
✅ January 2026: In the United States and global healthcare markets, Siemens Healthineers expanded its Artis icono biplane imaging platform with new software and workflow tools designed to improve precision and efficiency for complex interventional radiology procedures.

✅ December 2025: In North America and Europe, Philips Healthcare launched enhanced versions of its interventional imaging systems with real-time 3D visualization and AI-assisted guidance to support minimally invasive vascular, neuro, and oncology interventions.

✅ November 2025: In Asia Pacific (Japan and South Korea), Canon Medical Systems introduced updated interventional radiology suites with improved flat-panel detector technology and integrated dose-reduction analytics to enhance procedural safety and image quality.

✅ October 2025: Across global markets, GE HealthCare reported broader clinical adoption of its advanced interventional imaging platforms that combine high-resolution fluoroscopy with real-time 3D roadmapping to support precision in endovascular and oncology procedures.

✅ September 2025: In Europe, Shimadzu Corporation expanded its angiography system portfolio with new features for enhanced image clarity and workflow automation aimed at interventional radiology labs.

✅ August 2025: In North America, Canon Medical Systems and key hospital systems collaborated on clinical workflows that integrate AI-driven procedural planning tools with interventional imaging to facilitate improved outcomes and streamlined case management.

Key Players
Carestream Health | Esaote S.p.A. | GE HealthCare | Fujifilm Holdings Corporation | Hologic Inc. | Koninklijke Philips N.V. | Shimadzu Corporation | Siemens Healthineers AG | Canon Medical Systems Corporation | Samsung Medison | Others

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=interventional-radiology-market?sai-v
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K

Market Drivers

- Rising Preference for Minimally Invasive Procedures: Patients and clinicians are shifting toward image guided treatments that reduce recovery time, pain, and hospital stays.

- Increasing Prevalence of Chronic Diseases: Growing cases of cancer, cardiovascular disorders, and neurological conditions are driving demand for targeted interventional therapies.

- Advancements in Imaging and Catheter Technologies: High resolution imaging, robotics, and precision guided devices are improving procedural safety and outcomes.

- Expansion of Outpatient and Ambulatory Care Centers: Minimally invasive radiology procedures are increasingly performed in cost effective outpatient settings.

- Aging Global Population: Higher incidence of vascular and oncologic diseases among elderly patients is supporting sustained procedure volumes.

Industry Developments

- Launch of Next Generation Image Guided Devices: Manufacturers are introducing advanced catheters, embolization materials, and navigation systems for improved precision.

- Integration of AI and Robotics in Procedures: AI assisted imaging analysis and robotic navigation are enhancing accuracy and reducing procedural complexity.

- Growth of Drug Eluting and Biodegradable Technologies: Innovative materials are improving therapeutic effectiveness while minimizing long term complications.

- Strategic Collaborations and Training Initiatives: Partnerships between hospitals, device makers, and academic centers are expanding clinical expertise and adoption.

- Regulatory Approvals for Novel Interventional Therapies: Increasing clearances for minimally invasive oncology, vascular, and pain management solutions are accelerating market growth.

Regional Insights

North America - Holds 39% share: Advanced healthcare infrastructure, high adoption of minimally invasive treatments, and strong reimbursement frameworks drive leadership.

Europe - Holds 28% share: Established radiology networks, aging population, and supportive clinical guidelines sustain steady expansion.

Asia Pacific - Holds 24% share: Rapid healthcare modernization, rising chronic disease burden, and growing investment in medical technology accelerate demand.

Latin America - Holds 5% share: Expanding hospital capabilities and improving access to advanced procedures support gradual growth.

Middle East and Africa - Holds 4% share: Increasing healthcare investment and adoption of minimally invasive care contribute to emerging market development.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/interventional-radiology-market?sai-v

Key Segments

By Product Type
X rays account for a substantial share due to their widespread availability, rapid imaging capability, and cost effectiveness in guiding minimally invasive procedures. MRI scans are gaining importance for providing high resolution soft tissue visualization and radiation free imaging, supporting complex interventional planning. Fluoroscopy remains a core modality driven by real time imaging guidance during catheter based and vascular procedures. CT scans hold significant demand because of precise cross sectional imaging and improved accuracy in needle placement and procedural navigation. Ultrasound is expanding rapidly owing to portability, absence of ionizing radiation, and strong suitability for bedside and image guided interventions.

By Application
Angiography and embolization represent major segments supported by increasing prevalence of cardiovascular diseases and rising adoption of minimally invasive vascular treatments. Balloon angioplasty and catheter placement maintain strong clinical demand driven by interventional cardiology and peripheral vascular procedures. Biopsy procedures are expanding steadily due to growing cancer diagnosis rates and need for image guided tissue sampling. Cholangiography and genitourinary interventions contribute notable usage in hepatobiliary and urological disorder management. Other applications continue to grow with advancements in image guided therapeutic techniques across multiple specialties.

By End Users
Hospitals dominate the segment because of advanced imaging infrastructure, high patient volumes, and availability of multidisciplinary interventional care. Ambulatory surgical centers are witnessing rapid growth driven by preference for outpatient minimally invasive procedures, reduced costs, and shorter recovery times. Diagnostic centers maintain steady demand supported by expanding imaging services, early disease detection, and referral based interventional support. Other end users include specialty clinics and research institutions adopting advanced image guided technologies for clinical and investigative purposes.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.